NO922332L - Fremgangsmaate for fremstilling av faktoravhengige, humaneb-cellelinjer - Google Patents

Fremgangsmaate for fremstilling av faktoravhengige, humaneb-cellelinjer

Info

Publication number
NO922332L
NO922332L NO92922332A NO922332A NO922332L NO 922332 L NO922332 L NO 922332L NO 92922332 A NO92922332 A NO 92922332A NO 922332 A NO922332 A NO 922332A NO 922332 L NO922332 L NO 922332L
Authority
NO
Norway
Prior art keywords
cell lines
cross
dependent
humaneb
procedure
Prior art date
Application number
NO92922332A
Other languages
English (en)
Norwegian (no)
Other versions
NO922332D0 (no
Inventor
Jacques Banchereau
Francoise Rousset
Original Assignee
Schering Plough Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Corp filed Critical Schering Plough Corp
Publication of NO922332D0 publication Critical patent/NO922332D0/no
Publication of NO922332L publication Critical patent/NO922332L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0635—B lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/24—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/52—CD40, CD40-ligand (CD154)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Control Of El Displays (AREA)
  • Photosensitive Polymer And Photoresist Processing (AREA)
  • Materials For Medical Uses (AREA)
  • Silicon Polymers (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Peptides Or Proteins (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Light Receiving Elements (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO92922332A 1989-12-14 1992-06-12 Fremgangsmaate for fremstilling av faktoravhengige, humaneb-cellelinjer NO922332L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19890403491 EP0434879A1 (fr) 1989-12-14 1989-12-14 Méthode de production de lignées de cellules B humaines dépendantes d'un facteur
PCT/EP1990/002195 WO1991009115A1 (fr) 1989-12-14 1990-12-13 Procede de fabrication de lignees de lymphocytes b humains avec dependance selon le facteur

Publications (2)

Publication Number Publication Date
NO922332D0 NO922332D0 (no) 1992-06-12
NO922332L true NO922332L (no) 1992-06-12

Family

ID=8203014

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92922332A NO922332L (no) 1989-12-14 1992-06-12 Fremgangsmaate for fremstilling av faktoravhengige, humaneb-cellelinjer

Country Status (16)

Country Link
EP (2) EP0434879A1 (fr)
JP (1) JPH0789910B2 (fr)
AT (1) ATE135041T1 (fr)
AU (1) AU655759B2 (fr)
CA (1) CA2071886A1 (fr)
DE (1) DE69025772T2 (fr)
ES (1) ES2084146T3 (fr)
FI (1) FI922655A7 (fr)
IE (1) IE904498A1 (fr)
IL (1) IL96639A0 (fr)
MY (1) MY106561A (fr)
NO (1) NO922332L (fr)
NZ (1) NZ236425A (fr)
OA (1) OA09701A (fr)
WO (1) WO1991009115A1 (fr)
ZA (1) ZA909778B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874082A (en) * 1992-07-09 1999-02-23 Chiron Corporation Humanized anti-CD40 monoclonal antibodies and fragments capable of blocking B cell proliferation
US5397703A (en) * 1992-07-09 1995-03-14 Cetus Oncology Corporation Method for generation of antibodies to cell surface molecules
AU5098493A (en) * 1992-08-21 1994-03-15 Schering Corporation Cd40 ligand, anti cd40 antibodies, and soluble cd40
EP0619323A1 (fr) * 1993-04-09 1994-10-12 Schering-Plough Anticorps monoclonaux humains et procédé et matériel pour les faire
EP0659766A1 (fr) * 1993-11-23 1995-06-28 Schering-Plough Anticorps monoclonaux humains contre des cytokines humains et méthode de fabrication de tels anticorps
US5959085A (en) * 1993-11-23 1999-09-28 Schering Corporation Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
CA2188165C (fr) 1994-04-28 2007-08-28 Marilyn Kehry Methode de multiplication et differenciation des cellules b et leur utilisation
US6465251B1 (en) * 1996-11-13 2002-10-15 Dana-Farber Cancer Institute, Inc. Method of promoting b-cell proliferation and activation with CD40 ligand and cyclosporin
EP1033406A4 (fr) * 1997-10-27 2005-03-09 Sumitomo Electric Industries Inducteur pour la production d'un anticorps specifique de l'antigene, vecteur d'expression contenant le gene requis a cette fin, et procede pour induire la production de l'anticorps specifique de l'antigene
US7063845B2 (en) 2000-04-28 2006-06-20 Gemini Science, Inc. Human anti-CD40 antibodies
US7288252B2 (en) 2000-10-02 2007-10-30 Novartis Vaccines And Diagnostics, Inc. Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies
CA2658221C (fr) 2001-04-27 2012-11-27 Kyowa Kirin Co., Ltd. Anticorps monoclonal anti-cd40
GB2398783A (en) 2003-02-26 2004-09-01 Antonio Lanzavecchia A method for producing immortalised human B memory lymphocytes
EP1597280B2 (fr) * 2003-02-26 2016-08-24 Institute for Research in Biomedicine Production d'anticorps monoclonaux par transformation de lymphocytes b par le virus d'epstein barr
US8187817B2 (en) 2005-08-02 2012-05-29 Xbiotech, Inc. Diagnosis, treatment, and prevention of vascular disorders using IL-1 autoantibodies
US8568719B2 (en) 2009-08-13 2013-10-29 Crucell Holland B.V. Antibodies against human respiratory syncytial virus (RSV) and methods of use
EP2316920A1 (fr) * 2009-10-30 2011-05-04 BioNTech AG Expansion clonique de lymphocytes B
JP5744196B2 (ja) 2010-07-09 2015-07-08 クルセル ホランド ベー ヴェー 抗ヒト呼吸器多核体ウイルス（ｒｓｖ）抗体および使用の方法
US20140287402A1 (en) 2011-06-27 2014-09-25 Valneva Method for screening cells

Also Published As

Publication number Publication date
ATE135041T1 (de) 1996-03-15
EP0434879A1 (fr) 1991-07-03
DE69025772T2 (de) 1997-02-06
NO922332D0 (no) 1992-06-12
IL96639A0 (en) 1991-09-16
MY106561A (en) 1995-06-30
AU6901791A (en) 1991-07-18
IE904498A1 (en) 1991-06-19
DE69025772D1 (de) 1996-04-11
AU655759B2 (en) 1995-01-12
EP0505397B1 (fr) 1996-03-06
ES2084146T3 (es) 1996-05-01
JPH0789910B2 (ja) 1995-10-04
WO1991009115A1 (fr) 1991-06-27
OA09701A (en) 1993-08-30
NZ236425A (en) 1993-02-25
EP0505397A1 (fr) 1992-09-30
FI922655A0 (fi) 1992-06-09
CA2071886A1 (fr) 1991-06-15
ZA909778B (en) 1991-10-30
JPH05503214A (ja) 1993-06-03
FI922655A7 (fi) 1992-06-09

Similar Documents

Publication Publication Date Title
NO922332L (no) Fremgangsmaate for fremstilling av faktoravhengige, humaneb-cellelinjer
DK154087C (da) Monoklonalt antistof, fremstilling heraf, hybrodimacellelinie til anvendelse ved fremstilling heraf, fremgangsmaade til anvendelse heraf samt diagnostisk praeparat indeholdende antistoffet
NO159888C (no) Monoklonalt antistoff.
DE3065072D1 (en) Process for producing antibodies to hepatitis virus and cell lines therefor
YU114680A (en) Method of obtaining monoclonal antibodies
DK95687D0 (da) Fremgangsmaade til chargevis dyrkning af animalske celler
ES2131527T3 (es) Anticuerpos monoclonales contra c-kit.
NO159621C (no) Monoklonalt antistoff.
DK517480A (da) Hybrid cellelinie og fremgangsmaade til fremstilling og anvendelse deraf
GB2000186A (en) Method of producing antibodies in vitro
IE46215L (en) Gamma-globulins, immune nucleic acids and immune dialysates.
NO159887C (no) Monoklonalt antistoff.
DK0587873T3 (da) Fremgangsmåde til opnåelse af celler, der er inficeret med en virus, der er forbundet med dissemineret sklerose
DK517180A (da) Hybrid cellelinie og fremgangsmaade til fremstilling og anvendelse deraf
ES8505406A1 (es) Procedimiento de obtener y aislar hibridomas secretores de anticuerpos, procedimiento de obtener anticuerpos y metodo de obtener polipeptidos
DE59812529D1 (de) Monoklonaler Antikörper 4G8B4B12 gegen humanes FLT3/FLK2
DE69430313D1 (de) Monoklonale antikörper, die flk-2-rezeptoren erkennen, und die isolierung primitiver hämatopoietischer stammzellpopulationen
DK439086D0 (da) Fremgangsmaader til anvendelse af cellelinier, der mangler humane klasseii histokompatibilitetsantigener
DE69431717D1 (de) BEHANDLUNG MITTELS EISEN-ENTZUG KOMBINIERT MIT IgG ANTIKÖRPER
SU1514768A1 (ru) ШТАММ ГИБРИДНЫХ КУЛЬТИВИРУЕМЫХ клеток животных ми5 миБсиьи5-продуцент моноклонального антитела к ре2 КОМБИНАНТНОМУ ФАКТОРУ НЕКРОЗА ОПУХОЛЕЙ-БЕТА ЧЕ
SU1529724A1 (ru) Штамм культивируемых гибридных клеток животного mus musculus - продуцент моноклонального антитела к термостабильному поверхностному антигену возбудителя сапа
ATE343596T1 (de) Humane monoklonale antikörper gegen inselzellantigen ia-2
SU1398393A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus, используемый для получения моноклональных антител к микобактериям туберкулеза
SU1692146A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus l. - продуцент моноклональных антител к 146 s-компоненту вируса ящура o
BG51639A1 (en) Hybridome cellular line mus musculus balb/c, secreting monoclonal antibody towards antigenous determinant of strain " hantaan " of the virus of haemorrhagic fever with nephritic syndrome